ACRS
Aclaris Therapeutics
$3.96
+$0.17 (+4.49%)Oct 28, 2026
Key metrics
The numbers that frame ACRS today
- Market cap
- $582.91M
- Gross margin
- 12.9%
- EV / Sales
- 68.6
- ROIC
- -59.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.10
- 52wk High
- $6.60
Growth
Revenue and earnings trend for ACRS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ACRS
Is Aclaris Therapeutics a good buy?
Hold. Aclaris Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Aclaris Therapeutics is selling at a very high price.
What is the market capitalization of ACRS?
Aclaris Therapeutics's market capitalization is $582.91M.
What is the 52-week high for ACRS stock?
The 52-week high for Aclaris Therapeutics is $6.60. The current close of $3.96 is 40% below that high.
What is the 52-week low for ACRS stock?
The 52-week low for Aclaris Therapeutics is $2.10. The current close of $3.96 is 88.6% above that low.
Does ACRS stock pay dividends?
Aclaris Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ACRS?
Aclaris Therapeutics's Debt / Equity ratio is 0.